Showing 1041-1050 of 1372 results for "".
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- Evio Beauty Supports Domestic Violence Survivorshttps://modernaesthetics.com/news/evio-beauty-supports-domestic-violence-survivors/2473319/Evio Beauty is teaming up with FreeFrom, a US-based non-profit organization dedicated to helping survivors of intimate partner violence achieve economic justice and long-term financial stability. Evio will donate one dollar from every sale of their Lip Serum (in any shade) to FreeFrom.
- FDA Clears Aesthetics Biomedical's Vivace Ultrahttps://modernaesthetics.com/news/fda-clears-aesthetics-biomedicals-vivace-ultra/2473317/The FDA has cleared Aesthetics Biomedical Inc.’s Vivace Ultra, the next generation and of personalized aesthetics, for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. An innovative reimagination and technical upgrade of the legacy Vivace
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i
- Curtis Cluff Named President and CFO of BioPhotas Inc.https://modernaesthetics.com/news/curtis-cluff-named-president-and-cfo-of-biophotas-inc/2473313/Curtis Cluff is the new President and Chief Financial Officer BioPhotas Inc., manufacturers of the Celluma series of light therapy devices. In this newly created role, Mr. Cluff will report to Patrick Johnson, Chief Executive Officer and inventor of the Celluma. &quo
- Right to Repair: How Developments Could Affect Aesthetics Practiceshttps://modernaesthetics.com/news/right-to-repair-how-developments-could-affect-aesthetics-practices/2473311/Recent action on the federal level has renewed interest in “Right to Repair” legislation, and the medical aesthetics industry is eyeing developments that might directly impact aesthetic practices and medspas. Right to Repair legislation dates back to the 1970s, and mos
- BeautyHealth’s Hydrafacial Teams Up with JLohttps://modernaesthetics.com/news/beautyhealths-hydrafacial-teams-up-with-jlo/2473309/The BeautyHealth Company is rolling out the Hydrafacial x JLo Beauty Booster. “I'm so excited to partner with Hydrafacial to create the new JLo Beauty Booster,” says founder of JLo Beauty Jennifer Lopez in a news release. “Hydrafacial is one of my favorite treatmen
- New Research Highlights the Efficacy and Safety Profile of Revance's DAXXIFYhttps://modernaesthetics.com/news/new-research-highlights-the-efficacy-and-safety-profile-of-revances-daxxify/2473304/Two new studies highlight the efficacy and safety profile of Revance Therapeutics, Inc.’s newly approved DAXXIFY (DaxibotulinumtoxinA-lanm). Glabellar injection of DAXXIFY showed a positive effect on eyebrow position, with a modest reduction in forehead muscle activity in&nbs
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra
- BTL Introduces EMFACEhttps://modernaesthetics.com/news/btl-introduces-emface/2473301/BTL is taking on the minimally invasive facial aesthetic category with the launch of EMFACE. Emface simultaneously emits both